General Surgery Center, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang, China.
Cancer Biol Ther. 2024 Dec 31;25(1):2424490. doi: 10.1080/15384047.2024.2424490. Epub 2024 Nov 6.
Cancer-associated fibroblasts (CAFs) can interact with macrophages in the tumor microenvironment by secreting extracellular vesicles (EVs), thereby affecting tumor progression. However, the mechanisms of CAF-secreted EVs in gastric cancer (GC) remain not well understood. Here, we investigated the effect of CAF-EVs on macrophage polarization in GC and the underlying mechanisms. Macrophage polarization was evaluated using flow cytometry and quantitative real-time polymerase chain reaction. GC cell proliferation was determined using cell counting kit-8, EdU, and colony formation assays. The molecular mechanism was explored using microarray analysis, dual-luciferase reporter assay, and RNA pull-down analysis. The results showed that CAFs secreted EVs that inhibit macrophage M1 polarization and promote M2 polarization. Moreover, miR-4253 expression was increased in CAF-EVs, and inhibition of miR-4253 reversed the macrophage polarization induced by EVs. IL6R was identified as the target of miR-4253. Additionally, macrophages treated with EVs that encapsulated miR-4253 promote GC cell proliferation. In conclusion, CAF-secreted EVs packaging miR-4253 facilitate macrophage polarization from M1 to M2 phenotype by targeting IL6R, thereby accelerating GC cell proliferation. The findings suggest that EV-encapsulated miR-4253 may be a promising therapeutic target of GC.
癌症相关成纤维细胞(CAFs)可以通过分泌细胞外囊泡(EVs)与肿瘤微环境中的巨噬细胞相互作用,从而影响肿瘤的进展。然而,CAF 分泌的 EV 在胃癌(GC)中的作用机制仍不清楚。在这里,我们研究了 CAF-EVs 对 GC 中巨噬细胞极化的影响及其潜在机制。通过流式细胞术和实时定量聚合酶链反应评估巨噬细胞极化。使用细胞计数试剂盒-8、EdU 和集落形成测定法测定 GC 细胞的增殖。使用微阵列分析、双荧光素酶报告基因测定和 RNA 下拉分析探讨了分子机制。结果表明,CAFs 分泌的 EV 抑制巨噬细胞 M1 极化并促进 M2 极化。此外,CAF-EVs 中 miR-4253 的表达增加,抑制 miR-4253 逆转了 EV 诱导的巨噬细胞极化。IL6R 被鉴定为 miR-4253 的靶标。此外,用包裹 miR-4253 的 EV 处理的巨噬细胞促进 GC 细胞的增殖。总之,CAF 分泌的 EV 通过靶向 IL6R 将巨噬细胞从 M1 极化为 M2 表型,从而促进 GC 细胞的增殖。研究结果表明,EV 包裹的 miR-4253 可能是 GC 的一个有前途的治疗靶点。